Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clinton Adds $35 Bil. Reserve To Permit Talks On Catastrophic Drug Benefit

Executive Summary

The Clinton Administration is adding catastrophic drug coverage to its Medicare drug benefit wish list, making the proposal more attractive to the biotech lobby.

You may also be interested in...



HHS Price-Setting Regs Could Be Authorized Under Democratic Medicare Plan

House Democrats are considering whether legislation to create a PBM-administered Medicare prescription drug benefit should allow HHS to issue rules ensuring that the Medicare program receives drugs at the same prices as other large group purchasers.

HHS Price-Setting Regs Could Be Authorized Under Democratic Medicare Plan

House Democrats are considering whether legislation to create a PBM-administered Medicare prescription drug benefit should allow HHS to issue rules ensuring that the Medicare program receives drugs at the same prices as other large group purchasers.

Gore Plan Would Pick Up $11 Bil. Of $23 Bil. Drug Spend By High-Cost Group

Vice President Gore's catastrophic coverage proposal for a Medicare prescription drug benefit is projected to cover outlier costs for about 3 mil. seniors, or 6%-7% of the Medicare population.

Related Content

UsernamePublicRestriction

Register

OM007016

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel